Most Recent
Construction PRO
Corporate advisory firm Cadence has left court worse off after bringing a defects suit against a builder and subcontractor on a residential development in New South Wales’ south coast, with the builder winning a $140,000 judgment on its cross-claim.
Two victims of collapsed investment firm Courtenay House have won a case against the real estate agent who persuaded them to invest hundreds of thousands of dollars into the $180 million Ponzi scheme.
ASIC has filed proceedings against Auto & General, alleging tens of thousands of Budget Direct customers lost discounts they were promised and were overcharged premiums for several years.
A judge has approved a $13.5 million settlement in a class action against the director of collapsed sandalwood producer Quintis, but has reduced deductions sought by the plaintiff's lawyers and funder, and denied a payout to the funder of a competing case.
A Federal Circuit Court judge who has been in the spotlight for his decisions has scolded a Perth law firm and barrister facing a sexual harassment case, after they sought to vacate the trial date due to counsel availability.
The director of a documentary about a US narcotics officer during the 1990s 'war on drugs' has won his copyright suit against the film's producers, with a judge finding his moral rights under the Copyright Act were infringed by their failure to credit him as the director.
AMP super members are set to receive $60 million in a class action stemming from the banking royal commission, with the average payout being under $100, a judge has heard.
Coles has told a court that its decision to change its discount policies was unsurprising during a period of significant inflation, denying claims by the ACCC that its ‘Down Down’ promotions were misleading.
Traditional land owners in the central Pilbara have filed a class action to force the removal of dumped asbestos waste, some 60 years after the Wittenoom asbestos mines closed and the town was struck from the map.
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.